Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rapid and significant reduction in rotavirus gastroenteritis in children in following the introduction of universal rotavirus vaccination in Palestine

Next Previous
Trial Profile

Rapid and significant reduction in rotavirus gastroenteritis in children in following the introduction of universal rotavirus vaccination in Palestine

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Jun 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ORV 116E (Primary)
  • Indications Gastroenteritis; Rotavirus infections
  • Focus Therapeutic Use

Most Recent Events

  • 25 Jun 2020 New trial record
  • 21 Apr 2020 Results presented at the 30th European Congress of Clinical Microbiology and Infectious Diseases

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top